A meta-analysis of 108 randomized controlled trials found garlic consumption was associated with improvements in several cardiovascular risk markers, including cholesterol, blood pressure, fasting blood glucose and inflammation.
By yourNEWS Media Newsroom
A large review of randomized controlled trials has found that garlic consumption may help improve multiple markers tied to cardiovascular risk, adding modern clinical evidence to a medicinal tradition that dates back thousands of years.
The meta-analysis, published in Nutrition Reviews, examined 108 randomized controlled trials and found that regular garlic intake was associated with measurable improvements in total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, blood pressure, fasting blood glucose, insulin resistance and inflammatory markers. The findings applied across several forms of garlic, including raw garlic, aged garlic extract and powdered supplements.
Researchers reported that the effects were strongest among adults who already had elevated cardiovascular risk, including participants with hypertension, dyslipidemia or higher inflammatory scores. The authors said the analysis included a broader participant base than many pharmaceutical trials and represents one of the largest systematic reviews to date on garlic’s cardiovascular effects in humans.
The findings also build on garlic’s long history in traditional medicine. Historical records cited by researchers identify references to garlic in ancient medical traditions from Egypt, Greece, China, India and Rome. An article on Mercola.com noted that garlic’s medicinal use has been documented as far back as Sumerian clay tablets dating to 2600 B.C.
The review found that total cholesterol fell by more than 10 points among garlic users, while LDL cholesterol dropped by nearly 6 points. HDL cholesterol increased, and triglycerides declined. Blood pressure also improved, with systolic blood pressure falling by nearly 4 mmHg and diastolic pressure by almost 2 mmHg.
Those findings are consistent with earlier clinical evidence compiled in the PDR for Herbal Medicines, which stated that trials indicate garlic may reduce cholesterol and blood pressure. A review in the Handbook of Clinically Tested Herbal Remedies also documented two earlier trials in which raw garlic consumption was linked to a 15% reduction in cholesterol from baseline.
The new analysis strengthens the evidence because it pooled a much larger data set and found that garlic appeared to influence two major cardiovascular risk factors at the same time: lipid levels and blood pressure.
Researchers also reported improvements beyond cholesterol and blood pressure. Fasting blood glucose declined by nearly 3 mg/dL, insulin resistance scores improved and C-reactive protein, a key marker of inflammation, fell by 1.6 mg/L. The body’s overall antioxidant capacity also increased.
The authors attributed garlic’s effects to several biological pathways involving sulfur compounds such as allicin. These compounds may help reduce LDL oxidation, relax blood vessel walls, inhibit platelet clumping and support antioxidant activity.
Research on aged garlic extract has also identified antioxidant effects. A study published in Phytomedicine Research found that aged garlic extract and organosulfur compounds including S-allylcysteine and S-allylmercaptocysteine showed significant scavenging activity against active oxygen species. A report on NaturalNews.com noted that aged garlic contains compounds that support cardiovascular function and may help prevent plaque buildup in artery walls.
The study authors noted that garlic differs from many pharmaceutical interventions because it appears to affect several cardiovascular pathways at once. Statins primarily target LDL cholesterol, while blood pressure medications generally focus on one part of cardiovascular regulation. Garlic, by contrast, was associated with simultaneous improvements in lipids, blood pressure, glucose metabolism and inflammation.
The authors concluded that garlic intake significantly improves lipid profiles, glycemic markers, blood pressure and inflammatory biomarkers. They said the findings support garlic’s role as an accessible dietary intervention for people seeking to reduce cardiovascular risk, especially when used as part of a broader heart-healthy lifestyle.
The study does not suggest garlic should replace prescribed medications for people with diagnosed cardiovascular disease, hypertension or diabetes. Instead, the findings point to garlic as a potentially useful food-based strategy that may complement other medical and dietary approaches.
Researchers emphasized that garlic works best within a broader anti-inflammatory eating pattern. They recommended combining it with foods such as wild-caught fatty fish, organic dark leafy greens, fiber-rich plant foods and antioxidant-rich produce. They also noted the importance of reducing refined sugar, avoiding processed seed oils, managing chronic stress and getting adequate sleep.
The review adds to evidence that simple dietary choices can influence cardiovascular health. For adults at elevated risk, regular intake of garlic in raw, aged or powdered form may offer measurable benefits across several risk markers without relying on a single biological mechanism.
Original article
Comments